Iteos Therapeutics, Inc. ( (ITOS) ) has released its Q3 earnings. Here is a breakdown of the information Iteos Therapeutics, Inc. presented to ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

The company’s shares opened today at p10,290.00. Welford covers the Healthcare sector, focusing on stocks such as Sanofi, GlaxoSmithKline, and Novartis. According to TipRanks, Welford has an average ...

Constellation Energy is preparing to restart what's now called the Crane Clean Energy Center on Three Mile Island to supply ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...